Prospective Cohort Study on Epstein-Barr Virus Antibody and Cancer Risks
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY
The goal of this prospective cohort study is to investigate the associations between Epstein-Barr Virus (EBV) antibody levels and the risk of overall and site-specific cancer types in Southern China. The main questions it aims to answer are: Question 1: In addition to the established EBV-associated cancer types, such as lymphomas, nasopharyngeal carcinoma, and stomach cancer, whether EBV is associated with other cancer types? Question 2: What's the cancer burden attributed to EBV in Southern China?
Eligibility
Participation Requirements
Sex: All
Minimum Age: 30
Maximum Age: 69
Healthy Volunteers: t
View:
• Subject residents in Zhongshan or Wuzhou City;
• Subject has no medical record of prevalent cancer;
• Subject has psychical condition and well consciousness, and willingness to accept and cooperate with the study\'s follow-up procedures.
Locations
Other Locations
China
Wuzhou Red Cross Hospital
RECRUITING
Wuzhou
Zhongshan People's Hospital
RECRUITING
Zhongshan
Contact Information
Primary
Wei-Hua Jia
jiawh@sysucc.org.cn
86+020-87342327
Backup
Yong-Qiao He
heyq@sysucc.org.cn
86+020-87342410
Time Frame
Start Date: 2008-08-01
Estimated Completion Date: 2030-12-31
Participants
Target number of participants: 100000
Treatments
Zhongshan cohort, Guangdong, China
30-59 years old healthy participants in Zhongshan city.
Wuzhou cohort, Guangxi, China
30-69 years old healthy participants in Wuzhou city.
Related Therapeutic Areas
Sponsors
Collaborators: Wuzhou Red Cross Hospital, Zhongshan People's Hospital, Guangdong, China
Leads: Sun Yat-sen University